Abstract
Human immunodeficiency virus type 1 mutants that are resistant to inhibition by cyclosporins arise spontaneously in vitro during propagation in a HeLa-CD4+ cell line in the presence of a nonimmunosuppressive analog of cyclosporin A. Interestingly, the phenotype of all of the mutants examined is drug resistant and drug dependent, with both cyclosporin A and its analog. Four independently isolated mutants have been analyzed genetically by construction of recombinant proviruses in the NL4-3 parental strain background and subsequent testing of the chimeric viruses in HeLa cells. The cyclosporin-resistant, cyclosporin-dependent phenotype consistently transfers with a 1.3-kb fragment of gag, within which the four mutants share one of two possible single amino acid exchanges in a proline-rich stretch in the capsid domain of Pr55gag. These mutants provide the first evidence that mutations in human immunodeficiency virus type 1 gag confer resistance to cyclosporins; however, replication is conditional on the presence of the drug. In the T-cell line CEM, replication of the recombinant mutant viruses is also cyclosporin dependent. The drug-dependent replication in HeLa cells is stringent, and in the absence of cyclosporin only revertant viruses with the parental phenotype grow out of cultures infected with cyclosporin-dependent virus. In at least one isolate examined, the revertant phenotype appears to be due to suppressor mutations near the proline-rich region.
MeSH Terms
Amino Acid Sequence
Base Sequence
Cyclosporine/pharmacology
Drug Resistance
Genes, gag
HIV-1/drug effects,genetics,physiology
HeLa Cells
Humans
Molecular Sequence Data
Mutation
Virus Replication/drug effects
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Aberham C
Sandoz Forschungsinstitut, Vienna, Austria.
Weber S
Phares W
References (21)
21 references, click to expand
-
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
Antimicrob Agents Chemother. 1994 Aug;38(8):1763-72
PMID: 7527198
-
Functional association of cyclophilin A with HIV-1 virions.
Nature. 1994 Nov 24;372(6504):363-5
PMID: 7969495
-
Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.
J Virol. 1995 Apr;69(4):2451-61
PMID: 7884893
-
Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5381-5
PMID: 7777516
-
Cyclophilin: a specific cytosolic binding protein for cyclosporin A.
Science. 1984 Nov 2;226(4674):544-7
PMID: 6238408
-
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J Virol. 1986 Aug;59(2):284-91
PMID: 3016298
-
Use of eukaryotic expression technology in the functional analysis of cloned genes.
Methods Enzymol. 1987;152:684-704
PMID: 3657593
-
Envelope sequences of two new United States HIV-1 isolates.
Virology. 1988 Jun;164(2):531-6
PMID: 3369091
-
The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1.
Blood. 1988 Dec;72(6):1904-10
PMID: 2904290
-
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.
Nature. 1989 Feb 2;337(6206):473-5
PMID: 2644542
-
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
Nature. 1989 Feb 2;337(6206):476-8
PMID: 2492638
-
The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell.
Biochemistry. 1990 Mar 6;29(9):2205-12
PMID: 2186809
-
Genetic and molecular biological characterization of a vaccinia virus gene which renders the virus dependent on isatin-beta-thiosemicarbazone (IBT).
Virology. 1991 Jun;182(2):442-54
PMID: 2024483
-
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
J Virol. 1992 Apr;66(4):2232-9
PMID: 1548759
-
Kinetic properties of Escherichia coli ribosomes with altered forms of S12.
J Mol Biol. 1992 Apr 20;224(4):1011-27
PMID: 1569565
-
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8351-5
PMID: 1381509
-
WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.
J Virol. 1993 Mar;67(3):1246-54
PMID: 8382293
-
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
Cell. 1993 Jun 18;73(6):1067-78
PMID: 8513493
-
Genetic studies on the poliovirus 2C protein, an NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization.
J Mol Biol. 1994 Mar 11;236(5):1310-23
PMID: 8126722
-
Specific incorporation of cyclophilin A into HIV-1 virions.
Nature. 1994 Nov 24;372(6504):359-62
PMID: 7969494
-
Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
J Virol. 1995 Feb;69(2):814-24
PMID: 7815548